Clinical Trials
7 trialsNCT07495735 2026-03-27
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
Not yet recruiting
NCT06887348 2026-01-12
RPx
Replimune, Inc.
Recruiting
NCT06750159 2024-12-27
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
Peking Union Medical College Hospital
Not yet recruiting
NCT06637059 2024-10-15
Artificially Intelligent Model for Accurate Detection of HCC
Zhejiang University
Completed
NCT05292443 2024-02-23
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
Withdrawn
NCT05661786 2022-12-22
PILOT
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
NCT00767234 2016-07-11
Permission to Collect Blood Over Time for Research
Stanford University
Terminated